Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Acute Services Division MAN-F-265 Diagnostics Directorate West of Scotland Specialist Virology Centre Level 5, New Lister Building Glasgow Royal Infirmary 10-16 Alexandra Parade Glasgow, G31 2ER Version 6 – 6th JUNE 2016 WoSSVC Lab No: REQUEST FORM: Hepatitis B DNA testing for healthcare workers involved in EPP in accordance with Department of Health guidelines Please send TWO x 9ml blood in an EDTA bottle to West of Scotland Specialist Virology Centre, Level 5, New Lister Building, Glasgow Royal Infirmary, Glasgow, G31 2ER (Hays DX 6491304, Exchange Glasgow 94G) Tel: 0141 201 8722 Email: Dr Eleri Wilson-Davies ([email protected]) Occuptional Health Contact Name: Name & address for Result Occuptional Health Contact Tel: _________________________________________ Occuptional Health Contact Email: _________________________________________ _________________________________________ ID / NHS / CHI No: ___________________________ _________________________________________ Patient Surname _____________________________ _________________________________________ Patient Forename ____________________________ Name & address for Invoice D.O.B. _____/______/________ Gender Male/Female _________________________________________ Requesting physician: _________________________ _________________________________________ Specimen type: 9ml EDTA blood bottle x2 _________________________________________ Requesting Lab No: ___________________________ _________________________________________ Date sample collected _____/______/________ _________________________________________ Time sample collected __________________am / pm SECTION 2: TESTING (Tick the appropriate box) FIRST ASSESSMENT OF HBV POSITIVE HCW FOR EPP: Two samples taken MORE than one month apart. FIRST SAMPLE / SECOND SAMPLE (Delete as appropriate) SECTION 2: If this patient is on treatment please give details inc antiviral drug, duration, when the ANNUAL FOLLOW UP OF HCW NOT ON TREATMENT (PREVIOUSLY ASSESSED FOR treatment completed, as appropriate your patient. EPP): Twowas samples taken between one weektoand one month apart. FIRST SAMPLE / SECOND SAMPLE (Delete as appropriate) FIRST ASSESSMENT OF HCW ON APPROPRIATE ANTI-VIRAL TREATMENT FOR EPP: Two samples taken MORE than one month apart. FIRST SAMPLE / SECOND SAMPLE (Delete as appropriate) HCW CURRENTLY ON APPROPRIATE ANTI-VIRAL TREATMENT PREVIOUSLY ASSESSED FOR EPP: Checked every three months (the period should be taken from the date the previous blood sample was drawn, and not from the date the result was received). OTHER: _______________________________________________________________________ __________________________________________________________________________________ __________________________________________________________________________________ (FULL DETAILS REQUIRED OR TESTING WILL NOT BE PERFORMED) Delivering better health www.nhsggc.org.uk Tel: +44(0) 141-201 8722 Fax: +44(0) 141-201 8723 [email protected] http://www.nhsggc.org.uk/virology Clinical Lead for Virology: Celia Aitken Consultant Medical Virologist: Eleri Wilson-Davies Consultant Clinical Scientist: Rory Gunson Technical Services Manager: Stephen Hughes